In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer
Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7573-7588
DOI: 10.1016/j.apsb.2026.07.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Jia Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
- Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
Zitieren
APA
Yan, J., Lin, R., Liu, Q., Zhang, Y., Chen, H., Tong, F., Song, Y., Shi, Y., & Li, Y. (2026). In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer. Acta Pharmaceutica Sinica B, 16(11), 7573-7588. https://doi.org/10.1016/j.apsb.2026.07.030
Vancouver
Yan J, Lin R, Liu Q, Zhang Y, Chen H, Tong F, et al. In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer. Acta Pharmaceutica Sinica B. 2026;16(11):7573-7588. doi:10.1016/j.apsb.2026.07.030
BibTeX
@article{Yan2026,
author = {Yan, Jia and Lin, Ruyi and Liu, Qiyu and Zhang, Yatong and Chen, Hao and Tong, Fan and Song, Yujun and Shi, Yulong and Li, Yuan},
title = {In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {11},
pages = {7573--7588},
doi = {10.1016/j.apsb.2026.07.030}
}
EUVIMED